GlassScriptPhysician profile
Yolin Bueno
NPI 1194061150
$519.04
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $49.01 · 2021: $69.99 · 2022: $15.60 · 2023: $170 · 2024: $88.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $100.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $79.86 | 2023 | Vaxneuvance |
| United Therapeutics Corporation | $59.56 | 2024 | |
| Edwards Lifesciences Corporation | $58.37 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $53.94 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $41.89 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $41.61 | 2023 | |
| Acadia Pharmaceuticals INC | $31.65 | 2021 | |
| Lilly USA, LLC | $19.68 | 2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $17.54 | 2019 | |
| Aroa Biosurgery Incorporated | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolin Bueno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.